Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status

BACKGROUND/AIMS: Antiviral therapy (AVT) reduces the risk of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis B (CHB). This multicenter retrospective study investigated the effects of AVT and hepatitis B virus (HBV)-related factors on the risk of HCC development in a coh...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gut Liver
Hlavní autoři: Kim, Mi Na, Hwang, Seong Gyu, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Han, Kwang-Hyub, Kim, Seung Up, Ahn, Sang Hoon
Médium: Artigo
Jazyk:Inglês
Vydáno: Editorial Office of Gut and Liver 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6430437/
https://ncbi.nlm.nih.gov/pubmed/30602075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl18204
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky